about
Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.The treatment and survival of patients with triple negative breast cancer in a London populationCompleteness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates.Social differences in lung cancer management and survival in South East England: a cohort study.Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes.Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009.High lung cancer surgical procedure volume is associated with shorter length of stay and lower risks of re-admission and death: National cohort analysis in England.Recent trends in resection rates among non-small cell lung cancer patients in England.Mesothelioma incidence projections in South East England.APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study.Short-term breast cancer survival in relation to ethnicity, stage, grade and receptor status: national cohort study in England.Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization.Resection rate, hospital procedure volume and survival in pancreatic cancer patients in England: Population-based study, 2005-2009.Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries.Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer.Dietary factors, genetic susceptibility and somatic mutations in colorectal cancer: a prospective study.The effect of different comorbidities on survival of non-small cells lung cancer patients.Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms.Fruits, vegetables, and hMLH1 protein-deficient and -proficient colon cancer: The Netherlands cohort study.Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008.Oral cavity, pharyngeal and salivary gland cancer: disparities in ethnicity-specific incidence among the London population.The effect of emergency presentation on surgery and survival in lung cancer patients in England, 2006-2008.Dietary folate and APC mutations in sporadic colorectal cancer.Meat and fish consumption, APC gene mutations and hMLH1 expression in colon and rectal cancer: a prospective cohort study (The Netherlands).Tumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population–Based StudyLung cancer stage-shift following a symptom awareness campaignHigh Procedure Volume Is Strongly Associated With Improved Survival After Lung Cancer SurgeryThe effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patientsVariation in surgical resection for lung cancer in relation to survival: Population-based study in England 2004–2006Variation in geographical treatment intensity affects survival of non-small cell lung cancer patients in EnglandResponse of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniquesComparison of two techniques for lower oesophageal sphincter manometry: sleeve and sphinctometerTobacco smoking increases risk of colorectal cancerPrognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnosesDoes immediate breast reconstruction using free flaps lead to delay in the administration of adjuvant chemotherapy for breast cancer?Trends in incidence of small cell lung cancer and all lung cancerHow representative are colorectal, lung, breast and prostate cancer patients responding to the National Cancer Patient Experience Survey (CPES) of the cancer registry population in England? A population-based case control studyStereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer
P50
Q21261222-A143D2CA-3238-4161-A21E-34B1BD481313Q34302752-16E9913B-CA6C-4092-8EF1-DCCEB92245D4Q35108314-82B6FC8F-3F01-4EB5-9599-B7D1BF0D6972Q36008023-0DC67B83-7697-4626-ACFC-8A5F17F3CD90Q36087621-12BF1F0A-F70E-4DFB-839C-3C209921AD7BQ37599996-256359CB-624C-486E-8B7D-B64AA53511ECQ38407190-F5DE96B5-20FF-405A-A438-6CA006F1E920Q38432049-5B69C1EE-269A-4BDF-9CD8-3D820E2B45B6Q38434762-2D6C699E-BC41-4FDD-AD9D-E6AC24C4B57FQ38448849-1E1D42AA-A34E-4A6F-ADE6-1EBF69A2B596Q39250723-57CE63E3-0344-43A3-8BE9-8E7355350607Q39997469-D0D75006-2F88-4B09-93CA-3D106D4CCC5DQ40170733-13606DF4-3B37-4EAA-A9CA-0CAEE85C2A63Q40820012-E4081989-72EB-41E0-AB2F-B208C2B933BEQ43780404-7DAABA8F-6877-4310-A6AB-30BBE1F9887CQ44250737-2C189B1B-2B8A-44E0-A110-484BB991E497Q44484458-0447ED7C-3A35-4EA5-919E-9CCC0A5ECA0FQ46445876-681E1B5B-EC31-4449-A365-27511D328E43Q46609166-126BE261-2D43-4403-9AD8-AF227CD943E7Q46680430-EE3EAB14-F5BB-4729-BB93-1B29C95DFF19Q47875117-98DA7714-0A8C-41CA-B07C-91266F825A2CQ50449589-453B1348-A758-41D9-B4EA-260521A4AC72Q53339837-12D07234-AF73-4B77-B6B1-365CE0466097Q54478404-5D37EB9E-EFB7-4B59-92E9-870B733B17ADQ59265015-E86E0385-2138-4822-A643-6C69EF5AB510Q59825496-79AC43DB-D95D-4A9C-A222-A8D51A42C2D5Q59825838-01CF1B18-3AAB-4357-AA86-990E42FDB1DAQ59825910-38B83F53-45AD-45E4-B335-A6DD0B057AF0Q59826061-46EEA9ED-EE9F-4E1D-988D-C6F5791016BAQ59881926-9FE181C0-8CD0-472B-8785-30EF1D55B3AFQ73589814-1CBD89A5-B3F5-4084-96E1-6A4278794D92Q79933095-BC194AA0-8110-4B35-844A-B438E2792D4BQ80450346-07F847BF-4CD5-494D-A439-C43D2C61060EQ84356681-B43E3285-BF68-4EC4-B48B-DAB381003561Q84529948-BF7EBC95-8ACF-4D96-9D27-FA40FC8D7AFCQ84892476-C0BEF5BB-4DC8-4F47-9C5F-21931DF575C6Q92057383-9706E57C-837F-4500-90D6-2BA5C7EE4471Q92385563-1F20455F-186E-4806-9097-1C2171ACCF6E
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0001-8694-4819
@en
name
Margreet Lüchtenborg
@ast
Margreet Lüchtenborg
@en
Margreet Lüchtenborg
@es
Margreet Lüchtenborg
@nl
type
label
Margreet Lüchtenborg
@ast
Margreet Lüchtenborg
@en
Margreet Lüchtenborg
@es
Margreet Lüchtenborg
@nl
prefLabel
Margreet Lüchtenborg
@ast
Margreet Lüchtenborg
@en
Margreet Lüchtenborg
@es
Margreet Lüchtenborg
@nl
P106
P1153
8609611200
P31
P496
0000-0001-8694-4819